FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32963111000001102: Selexipag (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2016. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    100456901000001118 Selexipag (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    100457001000001119 Selexipag en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Selexipag Is a Vasodilator false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Selexipag 200microgram tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 400microgram tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 600microgram tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 800microgram tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1mg tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1.2mg tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1.4mg tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1.6mg tablets Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 400microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 600microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 800microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,200microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,400microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,600microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1.6mg tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1.4mg tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1.2mg tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 1mg tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 800microgram tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 600microgram tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 400microgram tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 200microgram tablets 140 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 200microgram tablets 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Selexipag 200microgram tablets 10 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 200microgram tablets (Janssen-Cilag Ltd) 10 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 200microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 200microgram tablets (Janssen-Cilag Ltd) 140 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 400microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 600microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 800microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,200microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,400microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier
    Uptravi 1,600microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient False Selexipag Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start